{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:54:25Z","timestamp":1781639665919,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine-related presenteeism is a global concern, arising when individuals attend work during a headache attack, resulting in reduced performance. To clarify this issue, we investigated the effect of the presence and severity of headache attacks on cognitive function in patients with migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of prospectively collected cohort data from April to December 2019, enrolling participants aged 18\u201380 years who met the ICHD-3 criteria for migraine. Participants were categorized into four groups based on headache (HA) intensity at the time of their clinic visit: no HA, mild, moderate, or severe. Cognitive function was assessed using the Digit Cancellation Test (D-CAT) and the Trail Making Test (TMT). Patients with severe HAs were excluded, as pain relief treatment was prioritized. Statistical comparisons were conducted across the remaining groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 259 patients were analyzed, including 125 without HAs (HA (\u2212)) and 134 with HAs (HA (+)), of whom 79 were mild and 55 were moderate. The HA (+) group showed significantly lower D-CAT scores compared with the HA (\u2212) group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), while TMT scores did not differ significantly between the two groups. Within the HA (+) group, no significant differences in D-CAT or TMT scores were observed between patients with mild and moderate HAs. Similarly, cognitive scores did not differ between migraine patients with and without aura.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Migraine patients experiencing a headache attack had reduced cognitive function compared with HA-free migraine patients, and this dysfunction was independent of HA severity. These findings suggest that the presence of a headache attack itself \u2013 regardless of its severity \u2013 may impair cognitive function and have potential implications for work efficiency and presenteeism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04782-z","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:52:49Z","timestamp":1772585569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognitive dysfunction during mild to moderate migraine attacks: potential implications for presenteeism"],"prefix":"10.1186","volume":"26","author":[{"given":"Yoji","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Shose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"4782_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"15","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci Jan. 2017;15:372:307\u201315. https:\/\/doi.org\/10.1016\/j.jns.2016.11.071.","journal-title":"J Neurol Sci Jan"},{"issue":"10440","key":"4782_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"18","author":"GBD Diseases","year":"2024","unstructured":"Diseases GBD, Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet May. 2024;18(10440):2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet May"},{"issue":"1","key":"4782_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1468-2982.1997.1701015.x","volume":"17","author":"F Sakai","year":"1997","unstructured":"Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia Feb. 1997;17(1):15\u201322. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1701015.x.","journal-title":"Cephalalgia Feb"},{"issue":"1","key":"4782_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10194-019-1062-4","volume":"5","author":"T Takeshima","year":"2019","unstructured":"Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain Dec. 2019;5(1):111. https:\/\/doi.org\/10.1186\/s10194-019-1062-4.","journal-title":"J Headache Pain Dec"},{"issue":"1","key":"4782_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"21","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain Apr. 2021;21(1):29. https:\/\/doi.org\/10.1186\/s10194-021-01243-5.","journal-title":"J Headache Pain Apr"},{"issue":"5","key":"4782_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139. . https:\/\/doi.org\/10.1212\/01.wnl.0000252808.97649.21.","journal-title":"Neurology"},{"issue":"1","key":"4782_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-020-01144-z","volume":"8","author":"LP Wong","year":"2020","unstructured":"Wong LP, Alias H, Bhoo-Pathy N, et al. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. J Headache Pain Jun. 2020;8(1):68. https:\/\/doi.org\/10.1186\/s10194-020-01144-z.","journal-title":"J Headache Pain Jun"},{"issue":"2","key":"4782_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/head.12026","volume":"53","author":"A Charles","year":"2013","unstructured":"Charles A. The evolution of a migraine attack - a review of recent evidence. Headache Feb. 2013;53(2):413\u20139. https:\/\/doi.org\/10.1111\/head.12026.","journal-title":"Headache Feb"},{"issue":"8","key":"4782_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1526-4610.2000.040008657.x","volume":"40","author":"K Farmer","year":"2000","unstructured":"Farmer K, Cady R, Bleiberg J, Reeves D. A pilot study to measure cognitive efficiency during migraine. Headache Sep. 2000;40(8):657\u201361. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.040008657.x.","journal-title":"Headache Sep"},{"issue":"8","key":"4782_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1526-4610.2000.040008638.x","volume":"40","author":"JS Meyer","year":"2000","unstructured":"Meyer JS, Thornby J, Crawford K, Rauch GM. Reversible cognitive decline accompanies migraine and cluster headaches. Headache Sep. 2000;40(8):638\u201346. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.040008638.x.","journal-title":"Headache Sep"},{"issue":"4","key":"4782_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1526-4610.2001.111006377.x","volume":"41","author":"K Farmer","year":"2001","unstructured":"Farmer K, Cady R, Bleiberg J, et al. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study. Headache Apr. 2001;41(4):377\u201384. https:\/\/doi.org\/10.1046\/j.1526-4610.2001.111006377.x.","journal-title":"Headache Apr"},{"issue":"4","key":"4782_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/head.12052","volume":"53","author":"KR Edwards","year":"2013","unstructured":"Edwards KR, Rosenthal BL, Farmer KU, Cady RK, Browning R. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function. Headache Apr. 2013;53(4):656\u201364. https:\/\/doi.org\/10.1111\/head.12052.","journal-title":"Headache Apr"},{"issue":"10","key":"4782_CR13","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1526-4610.2012.02218.x","volume":"52","author":"IP Martins","year":"2012","unstructured":"Martins IP, Gil-Gouveia R, Silva C, Maruta C, Oliveira AG. Migraine, headaches, and cognition. Headache Nov-Dec. 2012;52(10):1471\u201382. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02218.x.","journal-title":"Headache Nov-Dec"},{"issue":"1","key":"4782_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/head.12158","volume":"54","author":"F Le Pira","year":"2014","unstructured":"Le Pira F, Reggio E, Quattrocchi G, et al. Executive dysfunctions in migraine with and without aura: what is the role of white matter lesions? Headache Jan. 2014;54(1):125\u201330. https:\/\/doi.org\/10.1111\/head.12158.","journal-title":"Headache Jan"},{"issue":"11","key":"4782_CR15","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s10072-019-03973-6","volume":"40","author":"R Baschi","year":"2019","unstructured":"Baschi R, Monastero R, Cosentino G, et al. Visuospatial learning is fostered in migraine: evidence by a neuropsychological study. Neurol Sci Nov. 2019;40(11):2343\u20138. https:\/\/doi.org\/10.1007\/s10072-019-03973-6.","journal-title":"Neurol Sci Nov"},{"issue":"1","key":"4782_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1468-2982.2005.01001.x","volume":"26","author":"AJ Pearson","year":"2006","unstructured":"Pearson AJ, Chronicle EP, Maylor EA, Bruce LA. Cognitive function is not impaired in people with a long history of migraine: a blinded study. Cephalalgia Jan. 2006;26(1):74\u201380. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01001.x.","journal-title":"Cephalalgia Jan"},{"key":"4782_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2117\/psysoc.2012.246","volume":"55","author":"TY Hatta","year":"2012","unstructured":"Hatta TY, Ito K, Mase Y, Kabasawa M. Reliability and validity of the digit cancellation test, a brief screen of attention. Psychologia. 2012;55:246\u201356.","journal-title":"Psychologia"},{"issue":"2","key":"4782_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1073191115602552","volume":"24","author":"J Llinas-Regla","year":"2017","unstructured":"Llinas-Regla J, Vilalta-Franch J, Lopez-Pousa S, Calvo-Perxas L, Torrents Rodas D, Garre-Olmo J. The Trail Making Test. Assessment Mar. 2017;24(2):183\u201396. https:\/\/doi.org\/10.1177\/1073191115602552.","journal-title":"Assessment Mar"},{"issue":"4","key":"4782_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/01.jom.0000121151.40413.bd","volume":"46","author":"RZ Goetzel","year":"2004","unstructured":"Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med Apr. 2004;46(4):398\u2013412. https:\/\/doi.org\/10.1097\/01.jom.0000121151.40413.bd.","journal-title":"J Occup Environ Med Apr"},{"issue":"11","key":"4782_CR20","doi-asserted-by":"publisher","first-page":"e038987","DOI":"10.1136\/bmjopen-2020-038987","volume":"9","author":"H Igarashi","year":"2020","unstructured":"Igarashi H, Ueda K, Jung S, Cai Z, Chen Y, Nakamura T. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open Nov. 2020;9(11):e038987. https:\/\/doi.org\/10.1136\/bmjopen-2020-038987.","journal-title":"BMJ Open Nov"},{"issue":"7","key":"4782_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/JOM.0b013e31818180cb","volume":"50","author":"WF Stewart","year":"2008","unstructured":"Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. Work impact of migraine headaches. J Occup Environ Med Jul. 2008;50(7):736\u201345. https:\/\/doi.org\/10.1097\/JOM.0b013e31818180cb.","journal-title":"J Occup Environ Med Jul"},{"issue":"18","key":"4782_CR22","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1001\/jama.290.18.2443","volume":"12","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA Nov. 2003;12(18):2443\u201354. https:\/\/doi.org\/10.1001\/jama.290.18.2443.","journal-title":"JAMA Nov"},{"issue":"6","key":"4782_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2165\/00019053-199813060-00003","volume":"13","author":"MD Ferrari","year":"1998","unstructured":"Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics Jun. 1998;13(6):667\u201376. https:\/\/doi.org\/10.2165\/00019053-199813060-00003.","journal-title":"Pharmacoeconomics Jun"},{"issue":"1","key":"4782_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/JOM.0b013e31812006365","volume":"53","author":"SH Landy","year":"2011","unstructured":"Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS Assessing the impact of migraine onset on work productivity. J Occup Environ Med. 2011;53(1):74\u201381. . https:\/\/doi.org\/10.1097\/JOM.0b013e31812006365.","journal-title":"J Occup Environ Med"},{"issue":"1","key":"4782_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s10194-025-01998-1","volume":"14","author":"O Grodzka","year":"2025","unstructured":"Grodzka O, Dzagoevi K, Rees T, et al. Migraine with and without aura-two distinct entities? A narrative review. J Headache Pain Apr. 2025;14(1):77. https:\/\/doi.org\/10.1186\/s10194-025-01998-1.","journal-title":"J Headache Pain Apr"},{"issue":"1","key":"4782_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s10194-020-01166-7","volume":"6","author":"S Islamoska","year":"2020","unstructured":"Islamoska S, Hansen AM, Wang HX, et al. Mid- to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J Headache Pain Aug. 2020;6(1):98. https:\/\/doi.org\/10.1186\/s10194-020-01166-7.","journal-title":"J Headache Pain Aug"},{"issue":"1","key":"4782_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10194-022-01462-4","volume":"26","author":"L Gu","year":"2022","unstructured":"Gu L, Wang Y, Shu H. Association between migraine and cognitive impairment. J Headache Pain Jul. 2022;26(1):88. https:\/\/doi.org\/10.1186\/s10194-022-01462-4.","journal-title":"J Headache Pain Jul"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04782-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:16:15Z","timestamp":1781637375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04782-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4782"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04782-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Yamaguchi Clinic Institutional Review Board (IRB#1-2024) and followed the principles of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. The requirement for individual informed consent was waived by the Institutional Review Board due to the retrospective and anonymized nature of the data. If participants with cognitive impairment had been included, informed consent would have been obtained from their legal guardians or appropriate representatives. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}